JASON CHIEN, M.D., M.S.
Jason Chien, M.D., M.S. is Vice President, Disease Area Stronghold Leader for Respiratory Infections at Janssen. As a distinguished scientist, Jason has a deep commitment to reducing the burden of respiratory viral infections, especially in populations at the highest risk for morbidity and mortality.
Prior to joining the Johnson & Johnson Family of Companies, Jason was the Global Respiratory Lead at Gilead Sciences, leading the development priorities and commercial strategy for addressing respiratory and infection-related unmet needs in adults and children. He and his team advanced multiple antiviral, anti-inflammatory, and anti-fibrotic programs through early and late stage development.
Jason has also served as Associate Professor of Pulmonary and Critical Care Medicine at the University of Washington and Associate Member of the Fred Hutchinson Cancer Research Center.
Jason obtained his undergraduate degree from the University of Michigan, his medical degree from UMDNJ-New Jersey Medical School, and his Master’s degree in Genetic Epidemiology from the University of Washington. His post-graduate training includes an Internal Medicine Residency and Infectious Diseases Fellowship at Case Western Reserve University, and a Pulmonary and Critical Care Medicine Fellowship at the University of Washington.
- Pushing Back the Threat of Influenza: Reflecting on the WHO Global Influenza Strategy
- 3 Innovative Ways Researchers Are Rethinking How We Combat the Flu